KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Preferred Stock Liabilities (2020 - 2023)

LifeMD (LFMD) has disclosed Preferred Stock Liabilities for 4 consecutive years, with $5.0 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Preferred Stock Liabilities rose 16.06% year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Jun 2023, up 16.06%, and an annual FY2022 reading of $4.6 million, up 11.07% over the prior year.
  • Preferred Stock Liabilities was $5.0 million for Q2 2023 at LifeMD, up from $4.7 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $5.0 million in Q2 2023 and bottomed at $3.7 million in Q4 2020.
  • Average Preferred Stock Liabilities over 4 years is $4.2 million, with a median of $4.2 million recorded in 2022.
  • Peak annual rise in Preferred Stock Liabilities hit 16.06% in 2023, while the deepest fall reached 10.77% in 2023.
  • Year by year, Preferred Stock Liabilities stood at $3.7 million in 2020, then grew by 12.45% to $4.1 million in 2021, then grew by 11.07% to $4.6 million in 2022, then increased by 10.23% to $5.0 million in 2023.
  • Business Quant data shows Preferred Stock Liabilities for LFMD at $5.0 million in Q2 2023, $4.7 million in Q1 2023, and $4.6 million in Q4 2022.